NEWS

Our CEO, Mr. Hashimoto, and Professor Kakeya from the Graduate School of Pharmaceutical Sciences at Kyoto University, who is also our...

Title Newly Developed Highly Bioavailable Curcumin Formulation, curcuRouge™, Reduces Neutrophil/Lymphocyte Ratio in the Elderly: A...

Therabiopharma is part of the Kyoto University Life Science Showcase 2020, San Diego This event will introduce biotech startups with...

Therabiopharma CEO held a presentation at NCN (Nutrition Capital Network) showcasing the latest innovations on nutraceuticals and...

Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong...

Our recent progress on a water-soluble curcumin monoglucronide (CMG) will be presented at the GAP (Global Academic Programs) conference...